Skip to main content

News

Press Release
10/27/2020
‘No Time to Wait’ campaign launches to educate about symptoms of Atrial Fibrillation (AFib), Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) The Bristol Myers Squibb–Pfizer Alliance, with the support of leading advocacy organizations...
‘No Time to Wait’ campaign launches to educate about symptoms of Atrial Fibrillation (AFib), Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) The Bristol Myers Squibb–Pfizer Alliance, with the support of leading advocacy organizations...
‘No Time to Wait’ campaign...
10/27/2020
EP Lab Digest
Press Release
10/27/2020
RetinalGeniX™ Technologies, Inc. announced the launch of its RetinalCam™ Home Monitoring & Physician Alert System. The RetinalCam™ is an entirely new type of Ophthalmic device that will allow high-risk individuals to transmit digital...
RetinalGeniX™ Technologies, Inc. announced the launch of its RetinalCam™ Home Monitoring & Physician Alert System. The RetinalCam™ is an entirely new type of Ophthalmic device that will allow high-risk individuals to transmit digital...
RetinalGeniX™ Technologies,...
10/27/2020
EP Lab Digest
Press Release
10/27/2020
The Janssen Pharmaceutical Companies of Johnson & Johnson announced it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for a new indication to expand the use of...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for a new indication to expand the use of...
The Janssen Pharmaceutical...
10/27/2020
EP Lab Digest
Press Release
10/26/2020
A new model that uses machine learning, which is a type of artificial intelligence, may help predict which patients with kidney disease are at especially high risk of developing heartbeat irregularities. The findings come from a study that...
A new model that uses machine learning, which is a type of artificial intelligence, may help predict which patients with kidney disease are at especially high risk of developing heartbeat irregularities. The findings come from a study that...
A new model that uses machine...
10/26/2020
EP Lab Digest
Press Release
10/23/2020
Trial results showed consistent improvement in sleep disordered breathing, arousals, sleep architecture, and daytime sleepiness through 5 years. Respicardia has announced 5-year results from the remedē System Post Approval Study, assessing...
Trial results showed consistent improvement in sleep disordered breathing, arousals, sleep architecture, and daytime sleepiness through 5 years. Respicardia has announced 5-year results from the remedē System Post Approval Study, assessing...
Trial results showed consistent...
10/23/2020
EP Lab Digest
Press Release
10/23/2020
Remote Patient Monitoring service for consumers delivers medical devices, mobile application and monthly video check-in with licensed physician to drive improved health outcomes Company has entered into a strategic clinical relationship with...
Remote Patient Monitoring service for consumers delivers medical devices, mobile application and monthly video check-in with licensed physician to drive improved health outcomes Company has entered into a strategic clinical relationship with...
Remote Patient Monitoring...
10/23/2020
EP Lab Digest
Press Release
10/23/2020
Availability of physician-prescribed cardiac monitoring system will significantly improve screening and treatment of atrial fibrillation and other chronic heart conditions. LIVMOR, Inc., a leading digital health solutions company, announced...
Availability of physician-prescribed cardiac monitoring system will significantly improve screening and treatment of atrial fibrillation and other chronic heart conditions. LIVMOR, Inc., a leading digital health solutions company, announced...
Availability of...
10/23/2020
EP Lab Digest
Press Release
10/22/2020
Proceeds to Support Ongoing Clinical Development of InRhythm™, A First-of-its-Kind Inhaled Antiarrhythmic for Treatment of Paroxysmal Atrial Fibrillation (PAF) Positive Phase 2 Data Scheduled for Presentation at American Heart Association...
Proceeds to Support Ongoing Clinical Development of InRhythm™, A First-of-its-Kind Inhaled Antiarrhythmic for Treatment of Paroxysmal Atrial Fibrillation (PAF) Positive Phase 2 Data Scheduled for Presentation at American Heart Association...
Proceeds to Support Ongoing...
10/22/2020
EP Lab Digest
Press Release
10/22/2020
Accelerating speed to diagnosis, allowing immediate access to patient ECG data, and enabling new revenue streams for physicians credited in rapid sales growth for leading ECG analysis platform  Cardiac Insight, Inc., a healthcare innovator...
Accelerating speed to diagnosis, allowing immediate access to patient ECG data, and enabling new revenue streams for physicians credited in rapid sales growth for leading ECG analysis platform  Cardiac Insight, Inc., a healthcare innovator...
Accelerating speed to diagnosis,...
10/22/2020
EP Lab Digest
Press Release
10/19/2020
Bringing together science, technology, and comprehensive solutions to redefine what’s possible in healthcare As the world of healthcare and its dependence on auscultation continues to evolve, digital technology is being introduced to meet...
Bringing together science, technology, and comprehensive solutions to redefine what’s possible in healthcare As the world of healthcare and its dependence on auscultation continues to evolve, digital technology is being introduced to meet...
Bringing together science,...
10/19/2020
EP Lab Digest